February 26, 2013 ·
Leave a comment
For Immediate Release
February 21, 2013 (CHAPEL HILL, NC) Thought Leader Select, a North Carolina-based key opinion leader strategy company, announces the hiring of Heather Langan as research director.
In her new role at the company, Langan will lead profiling and engagement planning related to the skills and experience of both leading physicians and other health care professionals, as well as medical centers of excellence that advance the medical science. Life sciences companies use this research and advice for better strategic decision-making for collaborations with medical experts, as industry works with these experts to bring new treatments to market for better patient care and better public health outcomes.
Langan arrives at Thought Leader Select after a decorated career in human services, working and leading teams in developmental disabilities, family therapy, and mental health. In her most recent role at Duke University’s National Center for Child Traumatic Stress, Langan led quality assurance and continuous improvement at the premier center of excellence in the area of child trauma, influencing the treatment decisions in evidence-based clinics around the country.
Heather Langan holds two bachelor’s degrees, in philosophy and psychology, from the University of Utah. After graduation, Langan also earned a pair of master’s degrees in psychology and counseling, from Stephen F. Austin University and North ... read more »
TAGS: 
biopharmaceutical centers of excellence developmental disabilities Duke University family therapy health care professionals Heather Langan Human Services key opinion leaders KOL engagement KOL engagement planning KOL identification KOL profiling leading physicians medical research medicine mental health National Center for Child Traumatic Stress patient care Paul Meade public health outcomes Thought Leader Select
December 20, 2012 ·
Leave a comment
December 20, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a medical strategy engagement in pulmonology with a top Canadian biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating chronic obstructive pulmonary disorder (COPD), approached Thought Leader Select for support with scientific advisory boards and continuing health education (CHE) initiatives across multiple Canadian provinces. Having already worked with Thought Leader Select to form rosters of key opinion leaders in Canadian rheumatology and oncology circles, the company will formulate its panel of key experts in pulmonology by deploying Thought Leader Select’s team to assess the skills and experiences of physician specialists across the country.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of these leading experts in multiple areas where they collaborate to advance the science of medicine and patient care, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.
Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening key opinion leader relationships in the nursing and pharmacy communities, and a suite of tools to promote collaborative work with KOLs. Among these ... read more »
TAGS: advisory boards basic research biopharmaceutical biotechnology chronic obstructive pulmonary disorder clinical trials COPD deep-profiling health care professionals health care providers healthcare key opinion leaders KOL KOL deployment KOL engagement KOL identification KOL mapping KOL profiling KOLs medical devices Neil Mellor oncology KOLs pharmaceutical pharmaceuticals physicians pulmonology rheumatology KOLs Thought Leader Select thought leaders treatment guidelines
November 6, 2012 ·
Leave a comment
November 6, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement in Canada focused on key opinion leaders and medical centers of excellence in women’s health with an international biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products aimed at improving the health of women, approached Thought Leader Select for support in a variety of collaborative efforts with leading physicians and other health care professionals at leading universities, medical schools, teaching hospitals, and specialty clinics. The key opinion leaders represent medical experts within the Canadian obstetrics and gynecology community, with areas of sub-specialty including fertility and the treatment of uterine tumors.
Known for the versatility of applications for its in-house research and analysis, Thought Leader Select’s research group will analyze the skills and experience of specialists in multiple areas where they collaborate with leading physicians and other health care professionals, including registered nurses, physician assistants, nurse practitioners, clinical pharmacists, and medical researchers, to advance the science of medicine and patient care in women’s health, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.
Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening collaborative ... read more »
TAGS: biopharmaceutical company biotechnology Canadian KOLs centers of excellence Chapel Hill NC clinical research clinical trials deep-profiling drug development gynecology health care professionals health care providers healthcare key opinion leaders KOL KOL deployment KOL engagement KOL identification KOL mapping KOL profiling KOLs Kristen Smithwick medical experts medical research obstetrics scientific journal publishing Thought Leader Select thought leaders transparency treatment guidelines uterine tumors women's health
October 30, 2012 ·
Leave a comment
Thought Leader Select is a company focused on driving industry collaborations among biopharmaceutical, medical device, and diagnostics companies with leading medical experts and centers of excellence, with the ultimate goals of these collaborations being two-fold in purpose: better treatment options for patients and better outcomes for global public health. As part of our company’s mission, we work with multiple organizations to promote best practices that deliver ethical, transparent interactions among these various healthcare constituencies.
One of these groups is the recently-launched Medical Science Liaison Society, a global Non-Profit organization being led by the Chairman of the Board, Dr. Samuel Dyer. The MSL Society is filling a vital need for the expanding role of Medical Science Liaisons around the world, as they collaborate with KOLs, physicians, and other health care professionals to advance medical science together to improve the quality of life for patients everywhere.
Thought Leader Select’s Allison Murphy, a veteran MSL herself from her days working in the Endocrinology Medical Affairs unit at Eli Lilly and Company, recently sat down with Dr. Dyer to learn more about this emerging organization and the impact the MSL Society is having in promoting the role of Medical Science Liaisons in the pharmaceutical, biopharmaceutical, medical device, and diagnostics industries.
In ... read more »
TAGS: Allison Murphy biotechnology centers of excellence CRO Eli Lilly and Company health care professionals healthcare key opinion leader management key opinion leader relationships key opinion leaders KOLs medical affairs medical affairs conference medical device medical science Medical Science Liaison Society medical science liaisons MSL and Medical Affairs Networking Group LinkedIn MSL best practices MSL conferences MSL education MSL executives MSL experts MSL management MSL resources MSL World group LinkedIn off-label discussions pharmaceutical physicians publications Samuel Dyer scientific journals social media Thought Leader Select University of North Carolina at Chapel Hill School of Medicine
October 18, 2012 ·
Leave a comment
October 18, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement focused on medical centers of excellence in obesity with a top U. S. biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating the condition of obesity, approached Thought Leader Select for support with a variety of collaborative efforts, including medical science liaison outreach to leading universities, medical schools, teaching hospitals, and specialty clinics in this area. Having already worked with Thought Leader Select to form rosters of key opinion leaders in endocrinology, primary care, nursing, pharmacy, and long-term care in the treatment of type I and type II diabetes and obesity, the company has now chosen Thought Leader Select to pinpoint the leading centers of excellence in the treatment of obesity in the United States.
Known for the versatility of applications for its in-house research and analysis, Thought Leader Select’s research group will assess the skills and experience of selected centers, detailing the collaborative activities of leading physicians and other health care professionals, including registered nurses, physician assistants, nurse practitioners, clinical pharmacists, and medical researchers, the people who advance the science of medicine and patient care, through basic and clinical research, scientific journal ... read more »
TAGS: basic research biopharmaceutical industry biotechnology Brian Castle centers of excellence identification centers of excellence profiling centers of excellence strategy clinical pharmacists clinical research drug development endocrinology health care professionals key opinion leaders KOL identification KOL profiling KOL strategy long-term care medical device industry medical diagnostics medical researchers medical schools medical science medical science liaison outreach nursing obesity obesity centers of excellence obesity KOLs patient care pharmaceuticals pharmacy physician assistants physicians primary care medicine registered nurses scientific journal publishing specialty medical clinics teaching hospitals Thought Leader Select Thought Leader Select consulting group Thought Leader Select research group treatment guidelines type 1 diatbetes type 2 diabetes universities
October 4, 2012 ·
Leave a comment
(CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement in obesity with a top U. S. biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating the condition of obesity, approached Thought Leader Select for support with scientific advisory boards, consulting, and medical science liaison outreach to leading physicians in this area. Having already worked with Thought Leader Select to form rosters of key opinion leaders in endocrinology, primary care, nursing, pharmacy, and long-term care in the treatment of type I and type II diabetes, the company has now chosen Thought Leader Select to pinpoint the leading experts in the treatment of obesity in the United States.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of specialists in multiple areas where they collaborate with leading physicians to advance the science of medicine and patient care, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.
Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening key opinion leader relationships in the area of obesity, and a suite of tools to promote collaborative work ... read more »
TAGS: advisory boards biopharmaceutical biotechnology Brian Castle clinical research drug development health care professionals health care providers healthcare key opinion leader key opinion leaders KOL KOL engagement KOL identification KOL mapping KOL profiling KOLs medical experts medicine obesity obesity key opinion leaders obesity specialists public health
September 27, 2012 ·
Leave a comment
(CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement in gastroenterology with a top Canadian biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating type and type II diabetes, approached Thought Leader Select for support with scientific advisory boards and continuing health education (CHE) initiatives across multiple Canadian provinces. Having already worked with Thought Leader Select to form a roster of key opinion leaders in Canadian endocrinology circles, the company will round out its roster of key opinion leaders by deploying Thought Leader Select’s team to assess the skills and experiences of registered nurses and clinical pharmacists around the country.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of registered nurses and pharmacists in multiple areas where they collaborate with leading physicians to advance the science of medicine and patient care, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.
Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening key opinion leader relationships in the nursing and pharmacy communities, and a suite of tools to promote collaborative work with KOLs.
“Thought ... read more »
TAGS: advisory boards basic research biopharmaceutical biotechnology clinical pharmacists clinical research clinical trials deep-profiling diabetes health care professionals health care providers key opinion leader key opinion leaders KOL KOL engagement KOL identification KOL mapping KOL profiling medical experts Neil Mellor pharmaceuticals registered nurses Thought Leader Select type 1 diabetes type 2 diabetes
June 21, 2012 ·
Leave a comment
June 21, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement in gastroenterology with a top 10 global biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating exocrine pancreatic insufficiency (EPI), approached Thought Leader Select for support with scientific advisory boards in support of a new product initiative. To meet the strategic needs of the company’s advisory board activities in support of the new treatment, Thought Leader Select will deploy its in-house research group for an assessment of community-based key opinion leaders in gastroenterology throughout the United States.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of leading specialists in multiple areas where they advance the science of medicine and patient care, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.
For the national assessment, the Thought Leader Select research group will collaborate with a team of national key opinion leaders in gastroenterology to identify community-based physicians for grassroots-level scientific advisory work. Thought Leader Select will combine the key opinion leader recommendations with the experience data to optimize a pool of leading physicians with broad representation across multiple geographic ... read more »
TAGS: advisory boards biopharmaceutical clinical research community-based gastroenterologists EPI exocrine pancreatic insufficiency gastroenterology health care professionals health care providers healthcare key opinion leaders KOL KOL deployment KOL engagement KOL identification KOL mapping KOL profiling KOLs medical experts pharmaceutical physicians therapeutic areas Thought Leader Select
April 26, 2012 ·
Leave a comment
April 26, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of an inter-disciplinary infectious disease engagement with a top 10 global biopharmaceutical company.
The biopharmaceutical company, part of a select group of global leaders in drug development for the treatment of infectious diseases, approached Thought Leader Select for support with its development pipeline across the Canadian market. To meet the combined strategic needs of the company’s emerging pipeline in treating conditions like HIV and Hepatitis-C, Thought Leader Select will deploy its in-house research group for a multi-disciplinary assessment of the key opinion leader community in infectious diseases.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of leading specialists in the following areas:
Gastroenterology
Hepatology
Infectious Disease
Internal Medicine
For the first wave of the assessment, the Thought Leader Select research group will identify 50 physicians appropriate for compliant engagement in support of drug development for infectious diseases, across multiple Canadian provinces.
In the second phase of the assessment, Thought Leader Select’s in-house research group will engage in its exclusive, validated methodology of deep profiling, delivering objective assessments of the skills and experience of key opinion leaders across 14 areas where health care professionals define themselves as thought leaders, ... read more »
TAGS: basic and clinical research biopharmaecutical consulting firm diagnostics drug development gastroenterology geographic impact of key opinion leaders health care professionals Hepatitis C hepatology HIV infectious diseases internal medicine key opinion leader relationships key opinion leaders KOL KOL engagement KOL identification KOL mapping KOL profiling KOL strategy Kristen Smithwick market access medical affairs medical device medical marketing medical meetings speakers patient health payer marketing physicians pipeline planning pricing and reimbursement professional network mapping public health scientific journal publishing Thought Leader Select thought leaders in medicine treatment guidelines
March 14, 2012 ·
Leave a comment
Industry Insights from Brian Castle
As in nearly all other aspects of life, social media is fast becoming a dominant force in the world of healthcare. Leading centers of excellence—hospitals, clinics, research foundations, and universities—are utilizing social media to educate patients about medical resources and treatments on a daily basis. Biopharmaceutical companies are using social media to promote new medications and further educate patients about other wellness resources at their disposal to help with debilitating diseases and conditions.
Physicians and other healthcare professionals, like practically every other profession, are embracing social media at unprecedented levels, engaging with each other on everything from new medical devices to tough medical cases. Due to this rise in HCP use of social media, some have begun to question the very essence of what makes a key opinion leader in the medical profession.
Some of these questioners have gone a step farther, at their ultimate peril, in misinterpreting physician involvement in spaces like Twitter, Facebook, LinkedIn and physician-only social media networks like Sermo. They incorrectly perceive that social media participation is the new thought leadership. Last year, I sat in the audience for a presentation by a leader in the pharmaceutical industry. This person posited a talking point she’d heard from an executive at a physician-only social media network: “If you’re not in their social network, you’re not ... read more »
TAGS: basic research biopharmaceutical companies biotechnology Brian Castle centers of excellence clinical research diseases Facebook global KOL HCPs health care professionals healthcare hospitals key opinion leaders KOL engagement KOL identification KOLs LinkedIn local KOL medical clinics medical conditions medical congresses medical devices medical diagnostics medical meetings medical resources medical treatment options medications national KOL patient education pharmaceuticals physician-only social networks physicians public health regional KOL research foundations scientific journal publishing Sermo social media thought leader engagement thought leader identification Thought Leader Select thought leaders thought leadership treatment guidelines Twitter universities wellness
Older posts »
